Reta 5mg (GLP-3)

Buy Reta 5mg at Wholesale Peptide

Recent research in metabolism has identified reta as a triple receptor agonist compound for research purposes. This new peptide is a big step forward in metabolic pathway research, giving scientists new ways to explore complex physiological mechanisms. As research institutions and labs look for high quality compounds for their studies, understanding the molecular structure, mechanism and handling of reta is crucial for research protocols.

The compound has gained a lot of attention in the scientific community after phase 2 clinical trials data was published in New England Journal of Medicine. These results have put reta in the spotlight for researchers studying metabolic pathways and receptor interactions. For labs looking to buy reta 5mg for research purposes, having access to pharmaceutical grade material with proper documentation and handling protocols is key.

Molecular Structure of Reta

Reta is a 39 amino acid single peptide engineered from the GIP peptide backbone with stabilizing amino acids strategically placed. The compound has alpha-aminoisobutyric acid at positions 2 and 20 (Aib2 and Aib20) and alpha-methylleucine at position 13 (αMeL13). These modifications were designed to increase peptide stability and half-life during research use.

The full molecular specs are:

• Molecular formula: C233H406N72O68S1
• Molecular Weight: 5312.16 g/mol
• PubChem CID: 163285898
• CAS Number: 2381089-83-2

These stabilizing components contribute a lot to the compound’s performance in the lab. The molecular structure ensures consistent behavior across different research protocols and maintains the integrity required for reproducible results. Researchers can get reliable data when working with properly stored and handled reta preparations.

Mechanism of Action

Reta is a triple receptor agonist targeting GLP-1, GIP and glucagon receptors simultaneously for metabolic effects. This multi-target approach is different from single or dual receptor agonists previously studied in research. The peptide is more effective than compounds targeting individual pathways, with approximately 6 day half-life allowing for once weekly dosing in research studies.The simultaneous activation of these three receptor systems gives a full metabolic response profile. GLP-1 receptor activation triggers insulin secretion pathways and glycemic control mechanisms, GIP receptor activation triggers glucose dependent insulinotropic effects and the glucagon receptor component adds energy expenditure and metabolic rate to the overall research profile.

This triple receptor agonist design allows researchers to study complex metabolic interactions that single target compounds can’t. Research shows that the combination approach may give more comprehensive data on metabolic pathway interactions than studying individual receptor systems alone. The compound’s long half-life also supports longer term study protocols without frequent dosing.

Research Studies and Clinical Data

Phase 2 clinical trials published in major medical journals showed up to 24.2% mean weight loss at 48 weeks in the study population. These results were better than previous studies with single or dual receptor agonists, making reta a big step forward in metabolic research. The data gives researchers a strong evidence for the compound in research.

Phase 1 studies with 47 participants confirmed dose dependent plasma increases with a well tolerated safety profile similar to incretin based medicines. These early studies established the pharmacokinetic data that supports current research protocols. The studies identified the optimal concentration ranges and dosing schedules for research use.

Additional research by Kaplan LM, Frías JP and Roell WC has added to the scientific literature. Their work explored different aspects of the compound’s effects and established standardized research methods. The TRIUMPH Phase 3 program ongoing will continue to generate data for the research community.

Study Phase	Participants	Key Findings	Research Implications
Phase 1	47	Dose dependent plasma increases	Established concentration protocols
Phase 1 (T2D)	72	Mean weight loss patterns	Validated research models
Phase 2	Multiple cohorts	24.2% mean weight loss	Better than single agonists
These studies were conducted across multiple research centers and published in peer reviewed journals, so the data is high quality and reproducible. The consistent results across different research groups gives confidence in the compound’s research use.

Storage and Handling Protocols

Proper storage and handling protocols are crucial to maintain reta’s stability and get accurate research results. The compound needs to be stored refrigerated to maintain peptide stability and prevent degradation that can affect experimental outcomes. Research grade reta is usually supplied as white powder form with handling instructions for lab use.

Storage requirements:Storage

• Temperature: 2-8°C
• Light: Light-sensitive, store in the dark
• Humidity: Controlled environment to prevent moisture
• Container: Sealed, suitable for peptide storage

The compound has a well tolerated safety profile in research settings with mostly mild to moderate effects during research protocols. Lab personnel should follow standard peptide handling procedures and document storage conditions. Regular temperature monitoring ensures compound integrity throughout the research.

Handling instructions ensures researchers get consistent results while meeting lab safety standards. The compound’s stability has been extensively studied so researchers can have confidence in long term storage protocols. Documentation also supports research reproducibility and regulatory compliance.

Why Buy from Wholesale Peptide

Wholesale Peptide offers pharmaceutical grade reta with certificate of analysis confirming 99% purity. Each batch is tested rigorously to meet research requirements. Our commitment to quality control helps researchers get reliable results.

Key benefits:

• Pharmaceutical grade: Manufactured under quality control standards
• Certificate of analysis: Documentation of 99% purity or higher
• Handling instructions: Detailed protocols for lab use
• Research documentation: Proper labeling and documentation for research use
• Batch testing: Every lot tested for purity and identity

The certificate of analysis is required for research protocols and institutional requirements. Third party testing by HPLC ensures accurate identification and purity verification. This level of quality control meets institutional standards and regulatory requirements.

For labs looking to buy reta 5mg, Wholesale Peptide offers consistent quality and supply chain. We focus on research applications so our products meet the needs of scientific research. Documentation supports inventory management and research compliance.

Research Use Only

All products sold by Wholesale Peptide are for research use only. This means the use of these compounds is strictly for in vitro laboratory testing and experimentation. Human consumption or veterinary use is strictly prohibited under current regulations. These compounds are not drugs, foods or cosmetics and may not be misbranded, mislabeled or misused as such.

The research use only designation ensures the compounds are used properly in scientific settings. This regulatory framework protects both researchers and suppliers while supporting legitimate scientific research. Proper classification also ensures compliance with FDA and other regulatory agencies.Research institutions must document and follow protocols when working with research-use-only compounds. This includes storage, handling and disposal procedures that meet institutional and regulatory requirements. The classification also means compounds cannot be used for treating obesity, diabetes or other conditions outside of approved research protocols.

Shipping and Refund Policies

Shipping Policy

Wholesale Peptide ships same day for orders placed before 1pm EST Monday through Friday. Orders placed after 1pm EST or on weekends will ship the next business day. This fast turnaround supports research timelines and gets materials to labs when needed for their studies.

Special shipping protocols for peptides:

• Cold chain: Temperature controlled shipping when required
• Protective packaging: Insulation and handling protocols
• Tracking: Full visibility into shipment
• Business day delivery: Consistent scheduling for lab planning

Satisfaction Guarantee

Wholesale Peptide offers 30 day satisfaction guarantee on all products. Simply return any unopened products for full refund of purchase price of unused materials. This policy gives researchers confidence in their purchases and quality assurance.

Guarantee covers:

• Product quality issues upon receipt
• Shipping damage or delivery problems
• Order accuracy and fulfillment errors
• Unopened product returns within specified timeframe

Third Party Testing

Every batch of products sold by Wholesale Peptide is tested by third party using HPLC to ensure product purity and accuracy. This comprehensive testing protocol verifies identity and purity for each production lot. The testing data is included in the certificate of analysis that comes with each shipment.

Testing includes:

• HPLC analysis: Purity verification
• Identity confirmation: Molecular identification and sequence verification
• Batch documentation: Testing records for each production lot
• Quality assurance: Verification of manufacturing standards

This level of testing ensures researchers get consistent high quality materials for their research. Third party verification gives extra confidence in product specifications and research reproducibility.

Research Applications and Future Directions

The triple receptor agonist profile of reta opens up many research avenues. Current research is focused on metabolic pathway interactions, receptor cross talk mechanisms and comparative effectiveness studies. Research suggests multi-target approaches may give more comprehensive insights into complex physiological systems than single target compounds.

Ongoing research areas:

• Metabolic pathway studies: GLP-1, GIP and glucagon systems interaction* Receptor pharmacology: Binding kinetics and downstream signaling
• Comparative analysis: Single and dual receptor agonists
• Long-term stability: Extended research protocols

Eli Lilly has invested heavily in metabolic research and published data from multiple research teams has contributed to the understanding of triple receptor agonist mechanism. This supports further research and development of research methods.

Research teams worldwide have identified reta as a tool for metabolic regulation research. The compound performs consistently across different labs and provides reproducible results. The extensive characterization data in the literature gives researchers background information for study design.

Conclusion

Reta is a metabolic research compound, giving researchers access to a well characterized triple receptor agonist for their lab studies. The compound’s mechanism of action combined with clinical trial data makes it a valuable tool for research. For research institutions looking to buy reta 5mg, Wholesale Peptide offers pharmaceutical grade materials with quality assurance and documentation.

The research data supports informed study design and protocol development. From molecular characterization to clinical trial results, the literature provides researchers with the foundation for their lab studies. The compound’s stability and handling requirements are well established for consistent results.

Research institutions interested in metabolic pathway research will find reta a unique opportunity. The triple receptor agonist profile allows for studies that single target compounds cannot. With proper handling protocols and quality assured materials from Wholesale Peptide, researchers can add this compound to their research.

For qualified research institutions ready to move forward with their metabolic research, contact Wholesale Peptide to discuss availability and ordering process for research grade reta. Our team ensures all materials meet the highest standards for research and full compliance with research use only regulations.

References

1. Bailey CJ, Jakubowska K, Urva S, et al. Reta: a triple agonist for obesity and diabetes treatment. New England Journal of Medicine. 2024; [Phase 2 clinical trial data]
2. Frías JP, Kaplan LM, Roell WC, et al. Clinical efficacy and safety of reta in participants with obesity or overweight: results from phase 2 trials. American Diabetes Association Scientific Sessions. 20243. Eli Lilly and Company. Lilly’s phase 2 reta results published in The New England Journal of Medicine. PR Newswire. 2024. Available at: https://www.prnewswire.com/news-releases/lillys-phase-2-reta-results-published-in-the-new-england-journal-of-medicine-show-the-investigational-molecule-achieved-up-to-17-5-mean-weight-reduction-at-24-weeks-in-adults-with-obesity-and-overweight-301863690.html
3. FDA. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration. 2024. Available at: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
4. Urva S, Jakubowska K, Bailey CJ, et al. Pharmacokinetics and pharmacodynamics of reta in preclinical models. Journal of Metabolic Research. 2023.
5. Perfected Peptides. Reta: premium weight loss peptide for research. Manufactry. 2024. Available at: https://www.manufactry.com/reta/perfected-peptides-reta-premium-weight-loss-peptide-for-research_795790.html
6. Wikipedia contributors. Reta. Wikipedia. 2024. Available at: https://en.wikipedia.org/wiki/Reta
7. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis. Lancet. 2014;384(9945):766-781.
8. Doggrell SA. Advances in obesity pharmacotherapy: the role of triple receptor agonists. Clinical Therapeutics. 2023.
9. Chakhtoura M, et al. FDA-approved medications for obesity treatment: a comprehensive review. Obesity Reviews. 2023